首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1454093

抗腫瘤藥物市場，按類型、按疾病類型、按應用、按國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Anti-Neoplastic Agents Market, By Type, By Disease Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年03月11日 | 出版商:

AnalystView Market Insights | 英文 299 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

報告要點

2023年抗腫瘤藥物市場規模為1,247.1億美元，2024年至2032年CAGR為8.5%。

抗腫瘤藥物市場-市場動態

預計不斷成長的癌症患者人數將推動市場成長

由於人口老化、生活方式的改變以及更多接觸癌症危險因子等多種因素，全球癌症盛行率不斷增加。根據疾病管制與預防中心的數據，2020 年美國報告了 1,603,844 例新癌症病例，其中 602,347 人死於該疾病。這意味著每 10 萬人中有 403 例新病例和 144 例死亡。隨著全球癌症患者數量的不斷增加，對更多樣化、更有效的治療選擇（包括抗腫瘤藥物）的需求日益成長。這種需求直接促進了這些藥物市場的擴張。此外，藥物發現和開發技術的進步為市場的進一步成長提供了機會。然而，藥物開發的高成本可能會限制市場成長。

抗腫瘤藥物市場-關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 8.5% 左右的CAGR成長

根據類型細分，化療藥物預計將在 2023 年顯示最大的市場佔有率

從應用細分來看，2023年醫院是主導類型

按地區分類，亞太地區是 2023 年的主要收入來源

抗腫瘤藥物市場-細分分析：

全球抗腫瘤藥物市場根據類型、疾病類型、應用和地區進行細分。

市場依類型分為三類：生物製劑、個人化醫療、化療藥物和其他。化療藥物引領市場。化療藥物在抗腫瘤藥物市場中佔有相當大的佔有率，為癌症治療領域的製藥公司帶來了巨大的收入。

根據疾病類型，市場分為三類：胃腸癌、攝護腺癌、肺癌、乳癌和其他癌症。抗腫瘤藥物的市場因疾病類型而異，因為每種類型的癌症都需要不同的治療方法和治療藥物。

根據其應用，市場分為四個部分：醫院、診所、癌症復健中心和門診手術中心。醫院作為癌症治療的中心樞紐，在市場上佔據主導地位。患者在醫院接受全面的治療，包括手術、化療、放射治療、標靶治療和免疫治療。

抗腫瘤藥物市場-地理洞察

該市場在地理上遍佈北美、拉丁美洲、歐洲、亞太地區、中東和非洲，每個地區再按國家進一步細分。由於製藥公司為開發創新療法而進行的大量研發投資，預計亞太地區將引領市場成長。亞太地區的製藥公司正致力於廣泛的研究和開發，以創造新的抗腫瘤藥物，旨在發現更有效、更有針對性的癌症治療方法。特別是中國，2022年的研發撥款達到創紀錄的3.09兆元人民幣（4,430億美元），比前一年成長10.4%，作為其增強創新能力努力的一部分。國家統計局資料顯示，2022年我國R&D經費佔GDP比重為2.55%，較上年提高0.12個百分點。由於血液和血液相關疾病盛行率不斷上升，預計歐洲在預測期內將成為第二大市場區域。

抗腫瘤藥物市場-競爭格局：

由於對有效癌症治療的需求不斷增加、全球癌症負擔以及治療藥物的不斷創新，抗腫瘤藥物市場的競爭格局非常激烈。具有強大研發能力和成功藥物開發歷史的公司可能在推出突破性療法方面具有競爭優勢。競爭圍繞著市場准入和分銷策略展開，以確保抗腫瘤藥物有效地輸送給患者。這涉及與分銷商、藥房、醫院和醫療保健專業人員建立合作，以最佳化產品可用性和市場覆蓋範圍。

介紹
- 按地理位置分類的細分市場佔有率分析
北美洲
- 概述
- 北美抗腫瘤藥物主要製造商
- 北美市場規模和預測（按國家）
- 北美市場規模和預測（按類型）
- 北美市場規模和預測（按疾病類型）
- 北美市場規模和預測（按應用）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲抗腫瘤藥物主要製造商
- 歐洲市場規模和預測（按國家）
- 歐洲市場規模與預測（按類型）
- 歐洲市場規模與預測（按疾病類型）
- 歐洲市場規模和預測（按應用）
- 德國
- 義大利
- 英國
- 法國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
亞太地區 (APAC)
- 概述
- 亞太地區抗腫瘤藥物主要製造商
- 亞太地區市場規模與預測（按國家）
- 亞太地區市場規模與預測（按類型）
- 亞太地區市場規模與預測（按疾病類型）
- 亞太地區市場規模與預測（按應用）
- 印度
- 中國
- 日本
- 韓國
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
拉丁美洲
- 概述
- 拉丁美洲抗腫瘤藥物主要製造商
- 拉丁美洲市場規模與預測（按國家）
- 拉丁美洲市場規模與預測（按類型）
- 拉丁美洲市場規模與預測（按疾病類型）
- 拉丁美洲市場規模與預測（按應用）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲
- 概述
- 中東和非洲抗腫瘤藥物主要生產商
- 中東和非洲市場規模及預測（按國家）
- 中東和非洲市場規模及預測（按類型）
- 中東和非洲市場規模及預測（按疾病類型）
- 中東和非洲市場規模及預測（按應用）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 的其餘部分

第 11 章：主要供應商分析-抗腫瘤藥物產業

競爭儀表板
公司簡介
- Pfizer Inc
- Merck & Co.
- Bayer AG
- Bristul-Myers Squibb Company
- Amgen Inc.
- Boehringer Ingelheim GmbH
- F. Hoffmann-La Roche Ltd
- Novartis
- Celgene Corporation
- Aspen Holdings
- Baxter Healthcare Corporation
- Teva pharmaceutical Industries Ltd
- Takeda
- Genentech Inc.
- Others

第 12 章：360 度分析師視角

第 13 章：附錄

研究方法論
參考
縮寫
免責聲明
聯絡我們

簡介目錄圖表

Product Code: ANV2274

REPORT HIGHLIGHT

Anti-Neoplastic Agents Market size was valued at USD 124,710 Million in 2023, expanding at a CAGR of 8.5% from 2024 to 2032.

Antineoplastic agents, also known as anticancer drugs, make up a broad and varied category of medications. They are a key component of chemotherapy, targeting and eliminating mutated human cells. Despite their specific focus on abnormal cells, these drugs can also impact healthy cells. Their mechanisms of action may involve influencing cell survival or enhancing the immune system's ability to fight off irregular cells. Workers in healthcare settings, including pharmacists, pharmacy technicians, physicians, nurses, and even housekeeping staff, may face potential exposure to antineoplastic agents while handling and administering these medications, as well as disposing of contaminated waste materials.

Anti-Neoplastic Agents Market- Market Dynamics

Growing cancer Patient Population is anticipated to propel the market growth

The prevalence of cancer is increasing worldwide due to various factors such as the aging population, changes in lifestyle, and greater exposure to cancer risk factors. According to the Center for Disease Control and Prevention, there were 1,603,844 new cases of cancer reported in the United States in 2020, with 602,347 deaths attributed to the disease. This translates to 403 new cases and 144 deaths per 100,000 individuals. With the rising number of cancer patients globally, there is a growing need for more diverse and effective treatment options, including anti-neoplastic agents. This demand directly contributes to the expansion of the market for these drugs. Additionally, advancements in technology for drug discovery and development present opportunities for further growth in the market. However, the high cost of drug development may pose a constraint on market growth.

Anti-Neoplastic Agents Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2024-2032)

Based on Type segmentation, Chemotherapeutic Agents was predicted to show maximum market share in the year 2023

Based on Application segmentation, Hospitals was the leading type in 2023

On the basis of region, Asia pacific was the leading revenue generator in 2023

Anti-Neoplastic Agents Market- Segmentation Analysis:

The Global Anti-Neoplastic Agents Market is segmented on the basis of Type, Disease Type, Application, and Region.

The market is segmented into three categories according to Type: Biological Agents, Personalized Medicine, Chemotherapeutic Agents, and Others. Chemotherapeutic Agents lead the market. Chemotherapeutic agents make up a considerable portion of the anti-neoplastic agents market, contributing significantly to the revenue generated by pharmaceutical companies involved in cancer therapeutics.

The market is categorized into three groups according to the disease type: Gastrointestinal Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, and Others. The market for anti-neoplastic agents differs depending on the disease type, as each type of cancer necessitates distinct treatment methods and therapeutic agents.

The market is categorized into four segments according to its application: Hospitals, Clinics, Cancer Rehabilitation Centers, and Ambulatory Surgical Centers. Hospitals hold a dominant position in the market as they act as central hubs for cancer treatment. Patients receive a comprehensive range of therapies at hospitals, including surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy.

Anti-Neoplastic Agents Market- Geographical Insights

The market is geographically spread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa, with each region further segmented by countries. Asia Pacific is projected to lead the market growth, thanks to significant R&D investments made by pharmaceutical companies to develop innovative therapies. Pharmaceutical companies in Asia Pacific are focusing on extensive research and development to create new anti-neoplastic agents, aiming to discover more efficient and targeted treatments for cancer. China, in particular, allocated a record 3.09 trillion yuan (USD443 billion) for research and development in 2022, marking a 10.4 percent increase from the previous year as part of its efforts to boost innovation capabilities. According to the National Bureau of Statistics, China's R&D spending represented 2.55 percent of the GDP in 2022, a 0.12 percentage point rise compared to the previous year. Europe is anticipated to be the second largest market region during the forecast period, driven by the increasing prevalence of blood and blood-related disorders.

Anti-Neoplastic Agents Market- Competitive Landscape:

The competitive landscape in the anti-neoplastic agents market is fierce, driven by the increasing need for efficient cancer treatments, the global burden of cancer, and the constant innovation in therapeutic agents. Companies with strong research and development capabilities and a history of successful drug development are likely to have a competitive edge in introducing groundbreaking therapies. Competition revolves around market access and distribution tactics to guarantee the efficient delivery of anti-neoplastic agents to patients. This involves forming collaborations with distributors, pharmacies, hospitals, and healthcare professionals to optimize product availability and market reach.

Recent Developments:

In December 2023, Pfizer Inc. and Seagen Inc. have recently reached a definitive merger agreement, with Pfizer acquiring Seagen, a renowned global biotechnology company specializing in the development and commercialization of groundbreaking cancer medicines. The acquisition will be made at a price of USD229 in cash per Seagen share, resulting in a total enterprise value of USD43 billion.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTI-NEOPLASTIC AGENTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Pfizer Inc

Merck & Co.

Bayer AG

Bristul-Myers Squibb Company

Amgen Inc.

Boehringer Ingelheim GmbH

F. Hoffmann-La Roche Ltd

Novartis

Celgene Corporation

Aspen Holdings

Baxter Healthcare Corporation

Teva pharmaceutical Industries Ltd

Takeda

Genentech Inc.

Others

GLOBAL ANTI-NEOPLASTIC AGENTS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

Biological Agents
Personalized Medicine
Chemotherapeutic Agents
Others

GLOBAL ANTI-NEOPLASTIC AGENTS MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032

Gastrointestinal Cancer
Prostate Cancer
Lung Cancer
Breast Cancer
Others

GLOBAL ANTI-NEOPLASTIC AGENTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Hospitals
Clinics
Cancer Rehabilitation Centers
Ambulatory Surgical Centers

GLOBAL ANTI-NEOPLASTIC AGENTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1.Anti-Neoplastic Agents Market Overview

1.1.Study Scope
1.2.Market Estimation Years

2.Executive Summary

2.1.Market Snippet
- 2.1.1.Anti-Neoplastic Agents Market Snippet by Type
- 2.1.2.Anti-Neoplastic Agents Market Snippet by Disease Type
- 2.1.3.Anti-Neoplastic Agents Market Snippet by Application
- 2.1.4.Anti-Neoplastic Agents Market Snippet by Country
- 2.1.5.Anti-Neoplastic Agents Market Snippet by Region
2.2.Competitive Insights

3.Anti-Neoplastic Agents Key Market Trends

3.1.Anti-Neoplastic Agents Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
3.2.Anti-Neoplastic Agents Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
3.3.Anti-Neoplastic Agents Market Opportunities
3.4.Anti-Neoplastic Agents Market Future Trends

4.Anti-Neoplastic Agents Industry Study

4.1.PEST Analysis
4.2.Porter's Five Forces Analysis
4.3.Growth Prospect Mapping
4.4.Regulatory Framework Analysis

5.Anti-Neoplastic Agents Market: COVID-19 Impact Analysis

5.1.Pre-COVID-19 Impact Analysis
5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments

6.Anti-Neoplastic Agents Market Landscape

6.1.Anti-Neoplastic Agents Market Share Analysis, 2023
6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis

7.Anti-Neoplastic Agents Market - By Type

7.1.Overview
- 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
- 7.1.2.Biological Agents
- 7.1.3.Personalized Medicine
- 7.1.4.Chemotherapeutic Agents
- 7.1.5.Others

8.Anti-Neoplastic Agents Market - By Disease Type

8.1.Overview
- 8.1.1.Segment Share Analysis, By Disease Type, 2023 & 2032 (%)
- 8.1.2.Gastrointestinal Cancer
- 8.1.3.Prostate Cancer
- 8.1.4.Lung Cancer
- 8.1.5.Breast Cancer
- 8.1.6.Others

9.Anti-Neoplastic Agents Market - By Application

9.1.Overview
- 9.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
- 9.1.2.Hospitals
- 9.1.3.Clinics
- 9.1.4.Cancer Rehabilitation Centers
- 9.1.5.Ambulatory Surgical Centers

10.Anti-Neoplastic Agents Market- By Geography

10.1.Introduction
- 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2.North America
- 10.2.1.Overview
- 10.2.2.Anti-Neoplastic Agents Key Manufacturers in North America
- 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.2.5.North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.2.6.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.7.U.S.
  - 10.2.7.1.Overview
  - 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4.U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.2.7.5.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.8.Canada
  - 10.2.8.1.Overview
  - 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4.Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.2.8.5.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.Europe
- 10.3.1.Overview
- 10.3.2.Anti-Neoplastic Agents Key Manufacturers in Europe
- 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.5.Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.3.6.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.7.Germany
  - 10.3.7.1.Overview
  - 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4.Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.7.5.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.8.Italy
  - 10.3.8.1.Overview
  - 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4.Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.8.5.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.9.United Kingdom
  - 10.3.9.1.Overview
  - 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4.United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.9.5.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.10.France
  - 10.3.10.1.Overview
  - 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4.France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.10.5.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.11.Russia
  - 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3.Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.11.4.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.12.Netherlands
  - 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3.Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.12.4.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.13.Sweden
  - 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3.Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.13.4.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.14.Poland
  - 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3.Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.14.4.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.15.Rest of Europe
  - 10.3.15.1.Overview
  - 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4.Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.15.5.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.Asia Pacific (APAC)
- 10.4.1.Overview
- 10.4.2.Anti-Neoplastic Agents Key Manufacturers in Asia Pacific
- 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.5.Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.4.6.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.7.India
  - 10.4.7.1.Overview
  - 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4.India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.7.5.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.8.China
  - 10.4.8.1.Overview
  - 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4.China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.8.5.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.9.Japan
  - 10.4.9.1.Overview
  - 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4.Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.9.5.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.10.South Korea
  - 10.4.10.1.Overview
  - 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4.South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.10.5.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.11.Australia
  - 10.4.11.1.Overview
  - 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4.Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.11.5.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.12.Thailand
  - 10.4.12.1.Overview
  - 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4.Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.12.5.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.13.Indonesia
  - 10.4.13.1.Overview
  - 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4.Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.13.5.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.14.Philippines
  - 10.4.14.1.Overview
  - 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4.Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.14.5.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.15.Rest of APAC
  - 10.4.15.1.Overview
  - 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4.Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.15.5.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.Latin America
- 10.5.1.Overview
- 10.5.2.Anti-Neoplastic Agents Key Manufacturers in Latin America
- 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.5.Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.5.6.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.7.Brazil
  - 10.5.7.1.Overview
  - 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4.Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.7.5.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.8.Mexico
  - 10.5.8.1.Overview
  - 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4.Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.8.5.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.9.Argentina
  - 10.5.9.1.Overview
  - 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4.Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.9.5.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.10.Colombia
  - 10.5.10.1.Overview
  - 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4.Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.10.5.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.11.Rest of LATAM
  - 10.5.11.1.Overview
  - 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4.Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.11.5.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.Middle East and Africa
- 10.6.1.Overview
- 10.6.2.Anti-Neoplastic Agents Key Manufacturers in Middle East and Africa
- 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.5.Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.6.6.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.7.Saudi Arabia
  - 10.6.7.1.Overview
  - 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4.Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.7.5.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.8.United Arab Emirates
  - 10.6.8.1.Overview
  - 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4.United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.8.5.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.9.Israel
  - 10.6.9.1.Overview
  - 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4.Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.9.5.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.10.Turkey
  - 10.6.10.1.Overview
  - 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4.Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.10.5.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.11.Algeria
  - 10.6.11.1.Overview
  - 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4.Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.11.5.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.12.Egypt
  - 10.6.12.1.Overview
  - 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4.Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.12.5.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.13.Rest of MEA
  - 10.6.13.1.Overview
  - 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4.Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.13.5.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Anti-Neoplastic Agents Industry

11.1.Competitive Dashboard
11.2.Company Profiles
- 11.2.1.Pfizer Inc
- 11.2.2.Merck & Co.
- 11.2.3.Bayer AG
- 11.2.4.Bristul-Myers Squibb Company
- 11.2.5.Amgen Inc.
- 11.2.6.Boehringer Ingelheim GmbH
- 11.2.7.F. Hoffmann-La Roche Ltd
- 11.2.8.Novartis
- 11.2.9.Celgene Corporation
- 11.2.10.Aspen Holdings
- 11.2.11.Baxter Healthcare Corporation
- 11.2.12.Teva pharmaceutical Industries Ltd
- 11.2.13.Takeda
- 11.2.14.Genentech Inc.
- 11.2.15.Others

12.360 Degree Analyst View

13.Appendix

13.1.Research Methodology
13.2.References
13.3.Abbreviations
13.4.Disclaimer
13.5.Contact Us

簡介目錄圖表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Anti-Neoplastic Agents Market: Type Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Type
TABLE Global Anti-Neoplastic Agents Market, by Type 2019-2032 (USD Million)
TABLE Anti-Neoplastic Agents Market: Disease Type Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Disease Type
TABLE Global Anti-Neoplastic Agents Market, by Disease Type 2019-2032 (USD Million)
TABLE Anti-Neoplastic Agents Market: Application Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Anti-Neoplastic Agents Market, by Application 2019-2032 (USD Million)
TABLE Anti-Neoplastic Agents Market: Regional snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Anti-Neoplastic Agents Market, by Region 2019-2032 (USD Million)
TABLE North America Anti-Neoplastic Agents Market, by Country, 2019-2032 (USD Million)
TABLE North America Anti-Neoplastic Agents Market, by Type, 2019-2032 (USD Million)
TABLE North America Anti-Neoplastic Agents Market, by Disease Type, 2019-2032 (USD Million)
TABLE North America Anti-Neoplastic Agents Market, by Application, 2019-2032 (USD Million)
TABLE Europe Anti-Neoplastic Agents Market, by Country, 2019-2032 (USD Million)
TABLE Europe Anti-Neoplastic Agents Market, by Type, 2019-2032 (USD Million)
TABLE Europe Anti-Neoplastic Agents Market, by Disease Type, 2019-2032 (USD Million)
TABLE Europe Anti-Neoplastic Agents Market, by Application, 2019-2032 (USD Million)
TABLE Asia Pacific Anti-Neoplastic Agents Market, by Country, 2019-2032 (USD Million)
TABLE Asia Pacific Anti-Neoplastic Agents Market, by Type, 2019-2032 (USD Million)
TABLE Asia Pacific Anti-Neoplastic Agents Market, by Disease Type, 2019-2032 (USD Million)
TABLE Asia Pacific Anti-Neoplastic Agents Market, by Application, 2019-2032 (USD Million)
TABLE Latin America Anti-Neoplastic Agents Market, by Country, 2019-2032 (USD Million)
TABLE Latin America Anti-Neoplastic Agents Market, by Type, 2019-2032 (USD Million)
TABLE Latin America Anti-Neoplastic Agents Market, by Disease Type, 2019-2032 (USD Million)
TABLE Latin America Anti-Neoplastic Agents Market, by Application, 2019-2032 (USD Million)
TABLE Middle East and Africa Anti-Neoplastic Agents Market, by Country, 2019-2032 (USD Million)
TABLE Middle East and Africa Anti-Neoplastic Agents Market, by Type, 2019-2032 (USD Million)
TABLE Middle East and Africa Anti-Neoplastic Agents Market, by Disease Type, 2019-2032 (USD Million)
TABLE Middle East and Africa Anti-Neoplastic Agents Market, by Application, 2019-2032 (USD Million)

List of Figures

FIGURE Anti-Neoplastic Agents Market Segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter's Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2023
FIGURE Type segment market share analysis, 2023 & 2032
FIGURE Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Disease Type segment market share analysis, 2023 & 2032
FIGURE Disease Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Application segment market share analysis, 2023 & 2032
FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Regional segment market share analysis, 2023 & 2032
FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE North America Anti-Neoplastic Agents Market share and leading players, 2023
FIGURE Europe Anti-Neoplastic Agents Market share and leading players, 2023
FIGURE Asia Pacific Anti-Neoplastic Agents Market share and leading players, 2023
FIGURE Latin America Anti-Neoplastic Agents Market share and leading players, 2023
FIGURE Middle East and Africa Anti-Neoplastic Agents Market share and leading players, 2023
FIGURE North America market share analysis by country, 2023
FIGURE U.S. Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Canada Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Europe Anti-Neoplastic Agents Market share analysis by country, 2023
FIGURE Germany Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Spain Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Italy Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE France Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE UK Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Russia Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Netherlands Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Sweden Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Poland Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of the Europe Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Asia Pacific Anti-Neoplastic Agents Market share analysis by country, 2023
FIGURE India Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE China Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Japan Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE South Korea Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Australia Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Thailand Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Indonesia Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Phillipines Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of APAC Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Latin America Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Latin America Anti-Neoplastic Agents Market share analysis by country, 2023
FIGURE Brazil Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Mexico Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Argentina Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Colombia Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of LATAM Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Middle East and Africa Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Middle East and Africa Anti-Neoplastic Agents Market share analysis by country, 2023
FIGURE Saudi Arabia Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE United Arab Emirates Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Israel Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Turkey Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Algeria Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Egypt Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of MEA Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)